Encore Medical, Inc. (EMI)

Encore Medical develops transcatheter closure devices for heart defects, including the Encore PFO Closure Device for patent foramen ovale and the Encore ASD Closure Device for atrial septal defects. The company is currently conducting the PerFOrm trial, a randomized FDA study comparing its PFO device to currently approved devices.